about
MAPK pathway activation in pilocytic astrocytomaFBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastomaDriver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaMedulloblastoma exome sequencing uncovers subtype-specific somatic mutationsMechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions.Genome-wide analysis of subependymomas shows underlying chromosomal copy number changes involving chromosomes 6, 7, 8 and 14 in a proportion of cases.Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.Arhgap36-dependent activation of Gli transcription factors.Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.Epigenomic alterations define lethal CIMP-positive ependymomas of infancyEpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cystsGenomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme.The role of chromatin remodeling in medulloblastoma.Pilocytic astrocytoma: pathology, molecular mechanisms and markers.Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies.Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.From class waivers to precision medicine in paediatric oncology.Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.Real-time quantitative polymerase chain reaction (qPCR) analysis with fluorescence resonance energy transfer (FRET) probes reveals differential expression of the four ERBB4 juxtamembrane region variants between medulloblastoma and pilocytic astrocytLIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)confFuse: High-Confidence Fusion Gene Detection across Tumor Entities.Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.A novel method for rapid molecular subgrouping of medulloblastoma.Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations.Telomere dysfunction and chromothripsis.DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.Systematic identification of suspected anthelmintic benzimidazole metabolites using LC-MS/MS.Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.
P50
Q27006028-BD31E5AA-65C6-45D8-B14E-AADD55E174A1Q28391884-D1CE12FC-FD83-48AE-8CFE-38A43E6B2D39Q29616862-D319857E-4D87-4FA4-BF23-3F37BB97EEEFQ30040534-A6181E8E-2D2B-40A3-92CB-8E2893F04419Q30368617-7BE6F982-990F-4050-B3FD-445A20279635Q33327294-6C8C9F1C-07B0-4167-A5D7-41B88441D4B8Q33917715-1BC94C57-3E0D-4448-9628-AC5AEE5D281EQ34002623-5C346F52-3378-48D2-AAE8-0B5844DECCE7Q34193749-7006248D-856C-470E-BB3D-C61DA1C554B9Q34240198-DF07B40A-3EAD-43EF-B43B-51823A0D06A5Q37105120-467CFB94-7937-428D-A508-19C497440540Q37386688-20F7D9AF-061E-476C-BECE-5D69C361EDEBQ37565322-2AF6E2F6-A270-4EDE-8AC1-A874F6D84E31Q37666306-41929DF3-46ED-483F-A7C1-8272268254F3Q37719291-93710EA9-12E1-41B5-B953-2BD8C3094786Q38083796-6D7778EE-6D95-4101-9CCF-B20A54BE23FCQ38384754-927F5B6F-4ABF-44FB-B4C3-FC94053DAE5DQ38525123-50A399E7-9757-4990-B696-3B12A0E4D93FQ38629781-14773884-6288-45D4-B0B1-80E8A6251060Q38693385-BDB110C6-9E55-4EE9-971C-9990D1C7F591Q38961577-22BFD4E1-544B-4077-8A49-B64BB03C7460Q39391190-F2D5AECC-0AA2-4D82-B681-D53355276338Q41814700-C73CC809-0C11-4AC0-AAAD-4C9242EE2A3FQ42085653-755D2A56-128D-4812-89C9-803653E64768Q42370080-EBA564DD-EAE6-411D-9CD4-AFECDB8732AFQ42739353-10426193-7694-4550-A0E0-2FAA2C88FDA0Q47154860-46A727CD-BBF3-4031-8F5D-91DB2E4497FBQ47833819-6F28B310-F990-435A-B38D-DB45DEB63E12Q47851257-41E19F30-A837-43C8-8546-2D7CF5F50848Q48302173-27DC22A9-0AA1-434B-8BAB-C37BB22C8D04Q48824616-058AECBE-12F3-44AD-9B09-0A1F576C0065Q48922014-A5B033AD-7F98-4777-BCFE-2E164D9F77D8Q50063187-8CDD7D12-6E7C-4729-9BBF-65E515838E5CQ50064963-26F17C8C-8D11-45CA-9B2B-AE8DC4532F63Q50859079-42D630FB-4DA9-43B9-93C7-87D6BC40C3F6Q53124895-2B0FB054-86EF-4419-BF8A-C736399D1B05Q53818682-B7BF0AF4-B436-427A-A3A0-84B49C36787CQ53830664-1AA3A035-8708-4489-B5ED-C546B1E1315FQ54976713-65A5BDD4-2678-43FC-B00B-02CADFCFDF59Q55289701-0EAC3AF5-22CE-4621-ADD4-643A8B2176ED
P50
description
researcher, ORCID id # 0000-0002-2036-5141
@en
wetenschapper
@nl
name
David T. W. Jones
@ast
David T. W. Jones
@en
David T. W. Jones
@es
David T. W. Jones
@nl
type
label
David T. W. Jones
@ast
David T. W. Jones
@en
David T. W. Jones
@es
David T. W. Jones
@nl
prefLabel
David T. W. Jones
@ast
David T. W. Jones
@en
David T. W. Jones
@es
David T. W. Jones
@nl
P214
P1053
G-9588-2013
P106
P21
P214
P31
P496
0000-0002-2036-5141
P7859
viaf-310693606